CLINICA 100 TOP 10: Siemens Healthcare
This article was originally published in Clinica
Siemens Healthcare is a non-mover, staying at No 4 in our Clinica 100 league table. It is No 3 in our IVD list and No 2 in Imaging list (as our cut-of date is June 30, 2015*, we have taken Siemens’ figures from fiscal 2014 ending Sept 30, 2014). 2014 marked a year of major streamlining for Siemens as it focuses on its higher-growth, higher margin business. It divested its audiology business to private equity firm EQT in November that year, sold off its health IT business unit to Cerner in August and its microbiology diagnostic unit to Danaher in July. The three deals brought in significant cash for Siemens, with a total value of over $4.42bn.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.